Howard Hughes Medical Institute
Follow13F filer, CIK 810386, Chevy Chase, MD
Howard Hughes Medical Institute reported $630,440,155 across 2 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-24-011467
- Period
- 2024-09-30
- Reported value
- $630M
- Holdings
- 2
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| SPYadded | +238,000 | $137M |
| BIOAnew | +113,765 | $2.37M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
None.
Holdings, Q3 2024
Share positions as resolved from 13F-HR 0000950123-24-011467, largest first. % of portfolio is the value over $630,440,155, the sum of the share positions whose value is usable for ratios (method).
How Q3 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-24-011467 | base | 2024-11-14 | acceptance time not in the bulk data set |